New Patients Book a Weight Care consult Learn more about Direct Health Suffering With Intolerable Side-Effects
As the popularity of GLP-1 receptor agonists are being shown to benefit many chronic diseases over and above their effect on weight, John Deanfield, FRCP, FESC, professor of cardiology at the Institute of Cardiovascular Sciences at University College London, told Medical News Today
Constipation Slower digestion often means slower bowel movements
Hunger hormone suppression reaches near-peak levels by week 46 in most users
The goal during GLP-1 therapy is not simply caloric restriction it is nutrient-preserving weight loss
Cui SS, Feng XB, Zhang BH, Xia ZY, Zhan LY (2020) Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation